These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 14976782
21. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia. Ma H, Zhuang X. Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090 [Abstract] [Full Text] [Related]
22. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure. Robertson EN, Driessen JJ, Vogt M, De Boer H, Scheffer GJ. Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664 [Abstract] [Full Text] [Related]
23. A comparison of intubation conditions and time-course of action with rocuronium and mivacurium for day case anaesthesia. Pendeville PE, Lois F, Scholtes JL. Eur J Anaesthesiol; 2007 Jun; 24(6):546-50. PubMed ID: 17241507 [Abstract] [Full Text] [Related]
24. [The time-course of action of rapacuronium and mivacurium after early reversal following equally lasting relaxation]. Geldner G, Lang C, Hoffmann W, Hossfeld A, Weinberger J, Eble M, Blobner M. Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):594-9. PubMed ID: 12975739 [Abstract] [Full Text] [Related]
25. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium. Kansanaho M, Olkkola KT. Int J Clin Monit Comput; 1996 Nov; 13(4):217-24. PubMed ID: 9080242 [Abstract] [Full Text] [Related]
26. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure. Della Rocca G, Pompei L, Coccia C, Costa MG, Cecchini V, Vilardi V, Pietropaoli P. Minerva Anestesiol; 2003 Nov; 69(7-8):605-11, 612, 5. PubMed ID: 14564242 [Abstract] [Full Text] [Related]
27. No substitute for the intravenous route. Donati F, Guay J. Anesthesiology; 2001 Jan; 94(1):1-2. PubMed ID: 11135714 [No Abstract] [Full Text] [Related]
28. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567 [Abstract] [Full Text] [Related]
29. Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination. Naguib M. Anesthesiology; 1994 Aug; 81(2):388-95. PubMed ID: 8053589 [Abstract] [Full Text] [Related]
30. Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Atherton DP, Hunter JM. Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167 [Abstract] [Full Text] [Related]
31. Comparison of suxamethonium and different combinations of rocuronium and mivacurium for rapid tracheal intubation in children. Naguib M, Samarkandi AH, Ammar A, Turkistani A. Br J Anaesth; 1997 Oct; 79(4):450-5. PubMed ID: 9389261 [Abstract] [Full Text] [Related]
40. A comparison of neuromuscular effects, tracheal intubating conditions, and reversibility of rapacuronium versus mivacurium in female patients. Vanacker BF, Geerts E, Coppens S, van Iersel M. Anesth Analg; 2002 Apr; 94(4):876-8, table of contents. PubMed ID: 11916789 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]